Shares of Staples (SPLS) are down fractionally Wednesday on word the company's CEO has decided to step down after the failed merger with Office Depot (ODP) . Staples said CEO Ron Sargent and the board have mutually agreed that he will exit his position at the company's annual shareholder meeting on June 14. At that point Shira Goodman, Staples' President of North America Operations will step in as interim CEO while the company looks for a permanent replacement. Since the beginning of the year, Staples shares are down 7.5 percent, and roughly half of the retail giants market cap has evaporated over the past 12 months, as earnings dry up and Staples faces the broader challenges which are impacting the broader U.S. retail market. Sargent was instrumental in driving Staples to acquire Office Depot for $6.3 billion, a deal that was ultimately blocked over antitrust concerns.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.